Cryoport Inc (CYRX)
Official siteINDUSTRIALS • INTEGRATED FREIGHT & LOGISTICS • NASDAQ
Market Cap: $1.01B
Last updated: Nov 17, 2026 at 11:04 AM ET
Cryoport Inc (CYRX) Earnings: Report Dates and Results
Cryoport (CYRX) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Cryoport reported EPS of -$0.25, below the -$0.19 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CYRX has an expected report date of Mar 1, 2027.
CYRX Earnings Call
The latest CYRX earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, CYRX beat 12, missed 23 and matched 5. Revenue for the quarter ended Sep 30, 2026 was $50.22M, up 13.5% from $44.23M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.25 | -$0.19 | N/A | -31.58% | Miss | N/A | 3 | 0 up, 1 down | Nov 5, 2026 | $50.22M |
| Jun 30, 2026 | -$0.20 | -$0.20 | -$0.20 - -$0.17 | 0.00% | In line | N/A | 3 | 1 up, 0 down | Aug 6, 2026 | $48.97M |
| Mar 31, 2026 | -$0.19 | -$0.19 | -$0.22 - -$0.16 | 0.00% | In line | N/A | 4 | 0 up, 3 down | May 4, 2026 | $47.80M |
| Dec 31, 2025 | -$0.17 | -$0.21 | -$0.24 - -$0.18 | +19.96% | Beat | N/A | 4 | 0 up, 1 down | Mar 3, 2026 | $45.45M |
| Sep 30, 2025 | -$0.13 | -$0.19 | -$0.20 - -$0.18 | +31.58% | Beat | N/A | 4 | N/A | Nov 4, 2025 | $44.23M |
| Jun 30, 2025 | -$0.24 | -$0.22 | -$0.28 - -$0.18 | -9.09% | Miss | N/A | 4 | 1 up, 1 down | Aug 5, 2025 | $45.45M |
| Mar 31, 2025 | -$0.38 | -$0.26 | -$0.38 - -$0.17 | -46.15% | Miss | N/A | 3 | 0 up, 1 down | May 7, 2025 | $41.04M |
| Dec 31, 2024 | -$0.43 | -$0.31 | -$0.33 - -$0.29 | -39.39% | Miss | N/A | 4 | 0 up, 2 down | Mar 4, 2025 | $59.53M |
| Sep 30, 2024 | -$0.21 | -$0.22 | -$0.36 - -$0.15 | +4.55% | Beat | N/A | 9 | 1 up, 1 down | Nov 7, 2024 | $56.66M |
| Jun 30, 2024 | -$0.30 | -$0.40 | -$0.45 - -$0.33 | +25.00% | Beat | N/A | 10 | 0 up, 1 down | Aug 6, 2024 | $39.71M |
| Mar 31, 2024 | -$0.42 | -$0.37 | -$0.42 - -$0.19 | -13.51% | Miss | N/A | 10 | 1 up, 1 down | May 7, 2024 | $37.29M |
| Dec 31, 2023 | -$1.31 | -$0.29 | -$0.38 - -$0.07 | -351.72% | Miss | N/A | 10 | 0 up, 0 down | Mar 12, 2024 | $57.26M |
| Sep 30, 2023 | -$0.41 | -$0.29 | -$0.38 - -$0.18 | -41.38% | Miss | N/A | 9 | 0 up, 0 down | Nov 8, 2023 | $56.16M |
| Jun 30, 2023 | -$0.33 | -$0.23 | -$0.34 - -$0.11 | -43.48% | Miss | N/A | 9 | 0 up, 0 down | Aug 9, 2023 | $57.02M |
| Mar 31, 2023 | -$0.13 | -$0.25 | -$0.29 - -$0.04 | +48.00% | Beat | N/A | 9 | 0 up, 0 down | May 4, 2023 | $62.82M |
| Dec 31, 2022 | -$0.24 | -$0.19 | -$0.26 - -$0.10 | -26.32% | Miss | N/A | 9 | 0 up, 0 down | Feb 23, 2023 | $60.36M |
| Sep 30, 2022 | -$0.14 | -$0.15 | -$0.18 - -$0.06 | +6.67% | Beat | N/A | 9 | 0 up, 0 down | Nov 3, 2022 | $60.46M |
| Jun 30, 2022 | -$0.22 | -$0.20 | -$0.23 - -$0.07 | -10.00% | Miss | N/A | 9 | 0 up, 1 down | Aug 4, 2022 | $64.15M |
| Mar 31, 2022 | -$0.30 | -$0.30 | -$0.36 - -$0.11 | 0.00% | In line | N/A | 8 | 1 up, 3 down | May 5, 2022 | $52.30M |
| Dec 31, 2021 | -$0.11 | -$0.14 | -$0.19 - -$0.02 | +21.43% | Beat | N/A | 9 | 0 up, 0 down | Feb 24, 2022 | $56.44M |
| Sep 30, 2021 | -$0.15 | -$0.07 | -$0.18 - -$0.05 | -114.29% | Miss | N/A | 9 | N/A | Nov 4, 2021 | $56.69M |
| Jun 30, 2021 | -$0.14 | -$0.06 | N/A | -133.33% | Miss | N/A | 8 | N/A | Aug 5, 2021 | $56.19M |
| Mar 31, 2021 | -$0.11 | -$0.05 | -$0.26 - $0.06 | -120.00% | Miss | N/A | 8 | N/A | May 4, 2021 | $53.28M |
| Dec 31, 2020 | -$0.26 | -$0.11 | -$0.31 - $0.04 | -136.36% | Miss | N/A | 7 | N/A | Mar 1, 2021 | $48.36M |
| Sep 30, 2020 | -$0.14 | -$0.13 | -$0.15 - -$0.10 | -7.69% | Miss | N/A | 5 | N/A | Nov 5, 2020 | $11.17M |
| Jun 30, 2020 | -$0.15 | -$0.11 | -$0.14 - -$0.08 | -36.36% | Miss | N/A | 6 | N/A | Aug 6, 2020 | $9.39M |
| Mar 31, 2020 | -$0.11 | -$0.05 | -$0.07 - -$0.03 | -120.00% | Miss | N/A | 7 | N/A | May 7, 2020 | $9.77M |
| Dec 31, 2019 | -$0.05 | -$0.07 | -$0.09 - -$0.06 | +28.57% | Beat | N/A | 7 | N/A | Mar 5, 2020 | $9.24M |
| Sep 30, 2019 | -$0.05 | -$0.07 | -$0.10 - -$0.06 | +28.57% | Beat | N/A | 6 | N/A | Nov 7, 2019 | $9.58M |
| Jun 30, 2019 | -$0.08 | -$0.07 | -$0.08 - -$0.07 | -14.29% | Miss | N/A | 6 | N/A | Aug 8, 2019 | $8.46M |
| Mar 31, 2019 | -$0.08 | -$0.06 | N/A | -33.33% | Miss | N/A | 4 | N/A | May 2, 2019 | $6.65M |
| Dec 31, 2018 | -$0.08 | -$0.07 | -$0.08 - -$0.05 | -14.29% | Miss | N/A | 5 | N/A | Mar 7, 2019 | $5.69M |
| Sep 30, 2018 | -$0.07 | -$0.07 | -$0.09 - -$0.07 | 0.00% | In line | N/A | 5 | N/A | Nov 8, 2018 | $5.29M |
| Jun 30, 2018 | -$0.09 | -$0.06 | -$0.07 - -$0.06 | -50.00% | Miss | N/A | 4 | N/A | Aug 9, 2018 | $4.63M |
| Mar 31, 2018 | -$0.07 | -$0.08 | -$0.10 - -$0.08 | +12.50% | Beat | N/A | 4 | N/A | May 3, 2018 | $4.02M |
| Dec 31, 2017 | -$0.09 | -$0.07 | -$0.08 - -$0.04 | -28.57% | Miss | N/A | 4 | N/A | Mar 6, 2018 | $3.32M |
| Sep 30, 2017 | -$0.08 | -$0.07 | N/A | -14.29% | Miss | N/A | N/A | N/A | Nov 1, 2017 | $3.00M |
| Jun 30, 2017 | -$0.08 | -$0.08 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 8, 2017 | $2.92M |
| Mar 31, 2017 | -$0.10 | -$0.12 | N/A | +16.67% | Beat | N/A | N/A | N/A | May 4, 2017 | $2.71M |
| Dec 31, 2016 | -$0.25 | -$0.28 | N/A | +10.71% | Beat | N/A | N/A | N/A | Mar 13, 2017 | $2.23M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.92, after -$1.36 the year before. It was -$0.93 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.92 | N/A |
| Dec 31, 2024 | -$1.36 | N/A |
| Dec 31, 2023 | -$2.18 | N/A |
| Dec 31, 2022 | -$0.90 | N/A |
| Dec 31, 2021 | -$0.51 | N/A |
| Dec 31, 2020 | -$0.66 | N/A |
| Dec 31, 2019 | -$0.26 | N/A |
| Dec 31, 2018 | -$0.31 | N/A |
| Dec 31, 2017 | -$0.35 | N/A |
| Dec 31, 2016 | -$0.93 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,900 words across 14 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,926 | 14 | |
| 2026Q2 | Jun 30, 2026 | 3,581 | 11 | |
| 2026Q1 | Mar 31, 2026 | 4,557 | 15 | |
| 2025Q4 | Dec 31, 2025 | 4,902 | 12 | |
| 2025Q3 | Sep 30, 2025 | 6,093 | 13 | |
| 2025Q2 | Jun 30, 2025 | 5,455 | 15 | |
| 2025Q1 | Mar 31, 2025 | 4,925 | 12 | |
| 2024Q4 | Dec 31, 2024 | 5,776 | 15 |
2026Q3 Earnings Call
Opening remarks
Todd Fromer Host, KCSA Strategic Communications Thank you, operator. Before we begin today, I would like to remind everyone that this conference call contains certain forward-looking statements. All statements that address our operating performance, events, or developments we expect or anticipate occurring in the future are forward-looking statements. Forward-looking statements are based on management's beliefs and assumptions, and not on information currently available to our management team. Our management team believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events, and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in Item 1A, Risk Factors, and elsewhere in our annual report on Form 10-K filed with the Securities and Exchange Commission, and those described from time to time in the other reports that we file with the Securities and Exchange Commission. As a reminder, Cryoport has uploaded its third-quarter 2026 interview document to the main page of the Cryoport, Inc. website. This document provides a review of Cryoport's financial and operational performance and the general business outlook. Before I turn the call over to Jerry, please note that because of the strategic partnership that has been established with DHL Group and the related sale of CRYOPDP to DHL in June 2025, CRYOPDP's financials, which were previously a part of Cryoport's Life Sciences Services reportable segment, are now presented as discontinued operations. Please note that unless otherwise indicated, all revenue figures discussed today will refer to continuing operations. This includes Cryoport's fiscal year 2026 revenue guidance. It is now my pleasure to turn the call over to Mr. Jerrell W. Shelton, Chief Executive Officer of Cryoport. Jerry, the floor is yours.
Jerrell W. Shelton Chief Executive Officer Thank you, Todd. Good afternoon, everyone. With me today is our Chief Financial Officer, Robert S. Stefanovich; our Chief Scientific Officer, Dr. Mark W. Sawicki; and our Vice President of Corporate Development and Investor Relations, Thomas J. Heinzen. I am pleased to report that Cryoport delivered another strong quarter, with revenue of $50.2 million, representing 14% year-over-year growth. Life Sciences Services continued to be a key growth driver, with revenue increasing 18% and representing 57% of our total company revenue.
Frequently Asked Questions About CYRX
When is Cryoport's next earnings date?
Cryoport's next earnings report is expected for Mar 1, 2027.
Did CYRX beat earnings estimates last quarter?
No. Cryoport reported EPS of -$0.25 for the quarter ended Sep 30, 2026, below the -$0.19 estimate by 31.58%.
What EPS do analysts expect from CYRX next quarter?
The consensus EPS estimate for Cryoport for the quarter ending Dec 31, 2026 is -$0.18 from 11 analysts, with estimates from -$0.20 to -$0.17.
How often does CYRX beat earnings estimates?
Cryoport beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -9.33%.
CYRX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors